ZYPATT- pancreatic enzyme concentrate tablet

ZyPatt by

Drug Labeling and Warnings

ZyPatt by is a Animal medication manufactured, distributed, or labeled by Patterson Veterinary. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Each tablet contains a minimum of:

Lipase..............................9,000 USP units

Protease.........................57,000 USP units

Amylase..........................64,000 USP units

Description:

ZyPatt™ is a pancreatic enzyme concentrate of porcine origin.

Precautions:

Discontinue use in animals with symptoms of sensitivity or allergy.

USE IN SPECIFIC POPULATIONS

FOR ANIMAL USE ONLY

SPL UNCLASSIFIED SECTION

Manufactured by:

Neogen Corporation,

Lexington, KY 40511

Manufactured for:

Patterson Veterinary,

137 Barnum Rd.,

Devens, MA 01434

Pattersonvet.com

Made in USA

WARNINGS

KEEP OUT OF REACH OF CHILDREN

Indications:

As a digestive aid in replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.

Directions for use:

Dose is administered before each meal. Estimate dose according to the severity of the condition and weight of the animal.

Average dose/meal:

Dogs: 2-3 tablets

Cats: 1/2-1 tablet

STORAGE AND HANDLING

Store tightly closed container in a dry place at a temperature not exceeding 35°C (95°F).

SPL UNCLASSIFIED SECTION

Lot No.:

Exp. Date:

100ct Bottle

NDC #14043-401-85

PATTERSON®

VETERINARY

ZyPatt™

TABLETS

PANCREATIC ENZYME CONCENTRATE

CAUTION: Federal law restrics this drug to use by or on the order of a licensed veterinarian.

Net Contents:

100 Tablets

PV196NEO Rev. 04/18

500ct Bottle

NDC #14043-401-89

PATTERSON®

VETERINARY

ZyPatt™

TABLETS

PANCREATIC ENZYME CONCENTRATE

CAUTION: Federal law restrics this drug to use by or on the order of a licensed veterinarian.

Net Contents:

500 Tablets

PV197NEO Rev. 04/18

INGREDIENTS AND APPEARANCE

ZYPATT 
pancreatic enzyme concentrate tablet

Product Information
Product Type	PRESCRIPTION ANIMAL DRUG	Item Code (Source)	NDC: 14043-401
Route of Administration	Oral

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
PANCRELIPASE LIPASE (UNII: 8MYC33932O) (PANCRELIPASE LIPASE - UNII:8MYC33932O)	PANCRELIPASE LIPASE	9000 [iU]  in .517 g
PANCRELIPASE AMYLASE (UNII: YOJ58O116E) (PANCRELIPASE AMYLASE - UNII:YOJ58O116E)	PANCRELIPASE AMYLASE	64000 [iU]  in .517 g
PANCRELIPASE PROTEASE (UNII: 3560D81V50) (PANCRELIPASE PROTEASE - UNII:3560D81V50)	PANCRELIPASE PROTEASE	57000 [iU]  in .517 g

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	11mm
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 14043-401-85	51.7 g in 1 BOTTLE, PLASTIC
2	NDC: 14043-401-89	258.5 g in 1 BOTTLE, PLASTIC

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		05/31/2018

Labeler - Patterson Veterinary (006962500)